Dienogest
Back to searchMolecule Structure
Scientific Name
Dienogest
Description of the Drug
Dienogest is an oral progestin used for the treatment of endometriosis as monotherapy or contraception in combination with ethinylestradiol.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09123
http://www.drugbank.ca/drugs/DB09123
Brand Name(s)
Endometrion
Company Owner(s)
Bayer Healthcare Pharmaceuticals Inc, Watson Laboratories Inc
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL37293 | |
| DrugBank | DB09123 | |
| PubChem: Thomson Pharma | 14850078 | 14752221 |
| PubChem | 68861 | |
| LINCS | LSM-45823 | |
| Nikkaji | J23.763I | |
| EPA CompTox Dashboard | DTXSID80891478 | |
| DrugCentral | 871 | |
| ChemicalBook | CB4947237 | |
| Guide to Pharmacology | 7654 | |
| rxnorm | DIENOGEST | |
| PubChem: Drugs of the Future | 12012771 | |
| ChEBI | 70708 | |
| ZINC | ZINC000004215629 |
